Completion put back to 2020 as cost spirals
Further delays to the construction of pharmaceutical giant AstraZeneca’s new headquarters in Cambridge could push the building’s final price tag to more than £500m.
Completion of the Herzog & de Meuron-designed project is now expected in the first half of 2020, nearly three years behind schedule.
AstraZeneca, which develops treatments for heart disease, cancer and respiratory illnesses, had expected to move into the building, located on the Cambridge Biomedical Campus, in the latter part of last year.
You are not currently logged in.
Take out a subscription to BD and you will get immediate access to:
Get access to premium content subscribe today